医学临床研究
  2025年4月7日 星期一           首 页    |    期刊简介    |    编委会    |    投稿指南    |    期刊订阅    |    广告合作    |    留言板    |    联系我们    |    English
医学临床研究  2021, Vol. 38 Issue (7): 1028-1030    DOI: 10.3969/j.issn.1671-7171.2021.07.019
  论著 本期目录 | 过刊浏览 | 高级检索 |
MiR-221在卵巢癌患者血清中的表达水平及其临床意义
岳华, 王真*
西电集团医院妇产科,陕西 西安 710077
Serum Expression Level and Clinical Significance of MiR-221 in Patients with Ovarian Cancer
YUE Hua, WANG Zhen
Department of Obstetrics and Gynecology ,Xidian Group Hospital, Xi'an, Shaanxi, 710077
全文: PDF (1171 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 【目的】探讨MiR-221在卵巢癌患者血清中的表达水平及其临床意义。【方法】选取2015年1月至2020年1月在本院妇产科诊治的卵巢癌患者84例为研究对象,另外选取同期在本院健康体检志愿者84例作为对照组,检测血清中miR-221的相对表达量,分析miR-221相对表达量与卵巢癌患者疾病分期、淋巴结转移情况、病理分化、组织病理分型及预后的相关性。【结果】卵巢癌组血清miR-221相对表达量为7.15±2.61,高于对照组的2.10±0.49,差异有统计学意义(t=17.429,P<0.05);miR-221水平与卵巢癌疾病分期(P=0.043)、淋巴结转移(P=0.014)、病理分化类型(P<0.001)显著相关。截止至随访终点时间,84例患者共32例(38.1%)死亡,9例(10.7%)失访,43例(51.2%)存活。低水平组患者生存时间为(40.2±4.6)个月,显著高于高水平组患者的(29.3±3.6)个月,其差异有统计学意义(P<0.05)。【结论】卵巢癌患者血清miR-221水平较高,与疾病分期较晚、有淋巴结转移、病理分化、生存时间相关,血清miR-221高水平患者预后较差。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
岳华
王真
关键词 卵巢肿瘤/病理学免疫组织化学微RNAs预后    
Abstract:【Objective】To study the correlation between circulating miR-221 level and the prognosis of ovarian cancer patients. 【Methods】A total of 84 ovarian cancer patients admitted to the Department of Obstetrics and Gynecology of Xi'an XD Group Hospital from January 2015 to January 2020 were selected as the research objects. At the same time, 84 healthy volunteers in the same period in our hospital were selected as the control group. The relative expression of miR-221 in the patient's serum was determined, and the relationship of the circulating miR-221 level with the patient's disease stage, lymph node metastasis, pathological differentiation, histopathological type and prognosis were analyzed. 【Results】The relative expression of miR-221 in the serum of the ovarian cancer group was(7.152±2.61), which was higher than that of the control group(2.102±0.49); and the difference was statistically significant(t=17.429, P<0.05). The level of circulating miR-221 was significantly related to the stage of ovarian cancer(P=0.043), lymph node metastasis(P=0.014), and pathological differentiation type(P<0.001). By the end of the follow-up, a total of 32(38.1%) of 84 patients died, 9(10.7%) were lost to follow-up, 43(51.2%) were alive, and the median follow-up time was 30(4~51) months. The circulating miR-221 level was significantly correlated with overall survival(OS)(P<0.001), and the correlation coefficient was -0.775. The median survival time of patients in the low-level group was 42 months(40.2±4.6), and the median survival time of patients in the high-level group was 29 months(29.3±3.6). The OS of the low-level group was significantly better than that of the high-level group(P<0.001). 【Conclusion】The late disease stage, lymph node metastasis, and poor pathological differentiation of ovarian cancer patients are associated with higher circulating Mir-221 levels. The level of circulating miR-221 is significantly related to OS, and patients with lower levels of circulating miR-221 have a better prognosis.
Key wordsOvarian Neoplasms/PA    Immunohistochemistry    MicroRNAs    Prognosis
收稿日期: 2020-12-10     
中图分类号:  R737.31  
通讯作者: *E-mail:onco47@163.com   
引用本文:   
岳华, 王真. MiR-221在卵巢癌患者血清中的表达水平及其临床意义[J]. 医学临床研究, 2021, 38(7): 1028-1030.
YUE Hua, WANG Zhen. Serum Expression Level and Clinical Significance of MiR-221 in Patients with Ovarian Cancer. JOURNAL OF CLINICAL RESEARCH, 2021, 38(7): 1028-1030.
链接本文:  
http://journal07.magtech.org.cn/yxlcyj/CN/10.3969/j.issn.1671-7171.2021.07.019     或     http://journal07.magtech.org.cn/yxlcyj/CN/Y2021/V38/I7/1028
版权所有 © 2013 医学临床研究杂志社  湘ICP备13012052号-1
办公地址:湖南省长沙市芙蓉区新军路43号煤炭大院主办公楼6楼621、623、632、636室 邮编:410011 电话(传真):0731-84824007 E-mail:jcr_cs.hn@vip.163.com
技术支持:北京玛格泰克科技发展有限公司 技术支持:support@magtech.com.cn